Literature DB >> 9416783

Efficient designs for studying synergistic drug combinations.

R J Tallarida1, D J Stone, R B Raffa.   

Abstract

Distinguishing between pharmacologically additive and synergistic drug combinations requires experimental designs and statistical analyses that often require appreciable numbers of animals and much experimenter time. The current study employed a design in which individual dose-effect data from each drug were translated into theoretically additive total dose combinations, in a fixed drug proportion, in order to produce a composite additive dose-effect relation that could be compared with that of an actual mixture having the same proportion. Results from this approach, using a combination of intrathecal doses of morphine and clonidine, were virtually identical to those using isobolographic analysis of the same data set. Both analyses showed significant synergism for this combination and, in each method, it was not necessary to constrain the drug regression lines to parallelism. In contrast to the isobole approach, the use of the composite additive dose-effect relation also allows observation of the interaction over a range of effects while reducing the size of the data sets needed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9416783     DOI: 10.1016/s0024-3205(97)01030-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  20 in total

1.  Effect of the Combination of CI-988 and Morphine on Neuropathic Pain after Spinal Cord Injury in Rats.

Authors:  Junesun Kim; Youngkyung Kim; Suk-Chan Hahm; Young Wook Yoon
Journal:  Korean J Physiol Pharmacol       Date:  2015-02-25       Impact factor: 2.016

2.  Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone.

Authors:  Janice C Froehlich; Brett J Hausauer; Dennis D Rasmussen
Journal:  Alcohol Clin Exp Res       Date:  2013-07-22       Impact factor: 3.455

3.  Oligomerization of MrgC11 and μ-opioid receptors in sensory neurons enhances morphine analgesia.

Authors:  Shao-Qiu He; Qian Xu; Vinod Tiwari; Fei Yang; Michael Anderson; Zhiyong Chen; Shaness A Grenald; Srinivasa N Raja; Xinzhong Dong; Yun Guan
Journal:  Sci Signal       Date:  2018-06-19       Impact factor: 8.192

Review 4.  Oxycodone combinations for pain relief.

Authors:  R B Raffa; J V Pergolizzi; D J Segarnick; R J Tallarida
Journal:  Drugs Today (Barc)       Date:  2010-06       Impact factor: 2.245

5.  Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.

Authors:  Amy T Pierce; Joanna DeSalvo; Timothy P Foster; Athena Kosinski; Sandra K Weller; William P Halford
Journal:  J Gen Virol       Date:  2005-09       Impact factor: 3.891

Review 6.  The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations.

Authors:  Ronald J Tallarida; Robert B Raffa
Journal:  Pharmacol Ther       Date:  2010-05-28       Impact factor: 12.310

7.  Effects of serotonin (5-HT)1A and 5-HT2A receptor agonists on schedule-controlled responding in rats: drug combination studies.

Authors:  Jun-Xu Li; Caroline Crocker; Wouter Koek; Kenner C Rice; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2010-12-21       Impact factor: 4.530

8.  Selective GABA transporter inhibitors tiagabine and EF1502 exhibit mechanistic differences in their ability to modulate the ataxia and anticonvulsant action of the extrasynaptic GABA(A) receptor agonist gaboxadol.

Authors:  Karsten K Madsen; Bjarke Ebert; Rasmus P Clausen; Povl Krogsgaard-Larsen; Arne Schousboe; H Steve White
Journal:  J Pharmacol Exp Ther       Date:  2011-03-30       Impact factor: 4.030

9.  Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model.

Authors:  Jarogniew J Luszczki; Neville Ratnaraj; Philip N Patsalos; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-08       Impact factor: 3.000

10.  Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.

Authors:  Piotr Popik; Ewa Kozela; Martyna Krawczyk
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.